-
The Evolution of RBQM: From Regulatory Compliance to Proven ROI and Data Quality
Clinical Research NewsToday, RBQM offers not just regulatory compliance but the ability to add measurable value to drug development and sponsor organizations. However, many organizations are still operating with fragmented tools, static risk registers and reactive monitoring models. To unlock the true power of RBQM, the industry needs to embrace its potential as a live, operational oversight model.
Oct 6, 2026
-
Follow the Money: Phase 3 Thyroid Eye Disease, Pivotal Dravet Syndrome Gene Therapy, Pediatric Brain Cancer CAR T
Clinical Research News | Funding news from around the biotech space including investments in Phase 2 sepsis, leukemia peptide immunotherapy, colon cancer, Phase 1 obesity, atherosclerosis, more.
Oct 1, 2026
-
ARPA-H Launches Autism Program SPECTRA, Veeva Introduces AI Study Builder Agent, NIH Debuts PubMed Replication Tool
Clinical Research News | Alliance trial finds fractionated radiosurgery reduces recurrence after brain metastasis surgery; FDA clears CU Anschutz CAR T-cell trial for colorectal cancer; Syneos Health and Tufts CSDD study links trial performance to operating model design; and more.
Sep 30, 2026
